Fitbit (NYSE:FIT) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the European Union, for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib), a condition that affects more than 33.5 million people globally. 
Cerner Corporation is pleased to announce a new relationship with Hampshire and Isle of Wight (HIOW) health and care system to enable their population health management journey to transform the planning and delivery of health and care services across the region.
The initiative will see the implementation of Cerner’s population health management data platform, HealtheIntent ®, alongside HealtheEDW SM, a big data analytics solution.
A new type of technology for the NHS is expected to help re-energise the healthcare IT market, following the formal UK launch of Miya Precision by smart health tech company Alcidion.
Miya Precision integrates information from the healthcare organisation's current systems, uses it to automate routine tasks, care plans and pathways, and overlays existing data with advanced clinical decision support to make otherwise static information clinically valuable.
NHSX has awarded smart health informatics provider Alcidion a place on the Clinical Communications Procurement Framework, a new procurement vehicle intended to help the NHS phase out pagers by the end of next year.
The £3 million framework will allow trusts to procure Alcidion’s Smartpage product without the need for formal tendering.
Bayer and Informed Data Systems Inc. (One Drop), a US-based digital health company, today announced that they have entered into an agreement to jointly develop digital health products for multiple therapeutic areas. The aim of the collaboration is to provide integrated services empowering patients to manage certain conditions. 
The rapid deployment of healthcare technology has been one of the most commented features of the NHS’ response to the coronavirus pandemic. Yet a significant minority of patients cannot benefit from new, digital services; and risk being overlooked in the rush to go ‘digital first’ in a post-Covid reset. So what can be done to get digital inclusion onto the digital health agenda? 
New York-Tel Aviv based digital health company, AEYE Health, has developed an AI-based retinal screening system that provides analysis and diagnostic results within 60 seconds.
Retinal diseases such as diabetic retinopathy (DR), glaucoma, macular degeneration and hypertensive retinopathy are becoming a pandemic. Over a billion people worldwide, and over 75 million people in the US, are at high risk for loss of sight and require an annual retinal check.